99% Purity Ceftriaxone Sodium Powder Material Ceftriaxone Sodium Powder Ceftriaxone Sodium

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Solid
• Purity: >99%
• Model NO.: D-sung Ceftriaxone sodium
• Shelf Life: 2 Years
• CAS: 74578-69-1
• Mf: C18h17n8nao7s3
• MW: 576.56200
• Density: 1.96
• Melting Point: 155 Oc
• Refractive Index: 1.889
• Psa: 293.80000
• Logp: -0.70130
• Safety Instructions: 22-24-37-45
• Hazard Category Code: R42/43
• Mdl: Mfcd09749665
• Dangerous Goods Signs: Xn
• Name: Ceftriaxone Sodium
• Sepecific: COA
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-sung
• Origin: Shaanxi Xi′an
• HS Code: 3004909090
• Production Capacity: 10000kg/Month

Product Description

99% purity Ceftriaxone sodium powder Material Ceftriaxone sodium Powder Ceftriaxone sodium

Product Description

Product Details

Product Name	Ceftriaxone sodium
CAS	104376-79-6
MF	C18H16N8Na2O7S3.31/2H2O
MW	598.54
Melting Point	236 °C

Ceftriaxone sodium has an antibacterial spectrum similar to that of cefotaxime sodium. It has powerful effects on E. coli, E. pneumoniae, indole-positive Aspergillus, E. influenzae, Serratia marcescens, meningococcus and gonococcus; pneumococcus, streptococcus and Staphylococcus aureus are moderately sensitive to this product; it has certain effects on Pseudomonas aeruginosa, enterococcus, methicillin-resistant Staphylococcus and most of Bacteroides fragilis are resistant to this product.

Application&Function

Function
Ceftriaxone Sodium is an antibiotic useful for the treatment of a number of bacterial infections. Ceftriaxone Sodium is a third-generation cephalosporin.
1.Ear (otitis media caused by Haemophilus influenzae,Moraxella catarrhalis,and S. pyogenes.)
2.Nose,sinuses (sinusitis),Throat (tonsillitis,pharyngitis caused by S. pyogenes )
3.Chest and lungs (bronchitis, pneumonia caused by Streptococcus pneumoniae and Haemophilus influenzae)
4.And Urinary system and Uncomplicated gonorrhea caused by Neisseria gonorrhoeae.
Application
The main clinical infection for susceptible strains of meningitis, pneumonia, skin and soft tissue infections, peritonitis, urinary tract infections, gonorrhea, liver and gallbladder infection, surgical trauma, sepsis, and genital infections. As a treatment for gonorrhea has been first-line drugs.
Ceftriaxone injection is often used (in combination, but not direct, with macrolide and/or aminoglycoside antibiotics) for the treatment of community-acquired or mild to moderate health care-associated pneumonia. It is also a choice drug for treatment of bacterial meningitis. In pediatrics, it is commonly used in febrile infants between 4 and 8 weeks of age who are admitted to the hospital to exclude sepsis.
 

Specification